Technical Analysis for EWTX - Edgewise Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 16.17 | 1.44% | 0.23 |
EWTX closed up 1.44 percent on Friday, April 26, 2024, on approximately normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
Earnings due: May 9
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
50 DMA Resistance | Bearish | 0.00% | |
Shooting Star Candlestick | Bearish | 0.00% | |
Gapped Down | Weakness | 1.44% | |
NR7 | Range Contraction | 0.37% | |
Oversold Stochastic | Weakness | 0.37% | |
Stochastic Buy Signal | Bullish | 3.32% | |
Inside Day | Range Contraction | 3.32% | |
Oversold Stochastic | Weakness | 3.32% | |
Slingshot Bearish | Bearish Swing Setup | 7.23% |
Alert | Time |
---|---|
50 DMA Resistance | about 10 hours ago |
Rose Above 50 DMA | about 10 hours ago |
Up 5% | about 12 hours ago |
60 Minute Opening Range Breakout | about 12 hours ago |
Rose Above 20 DMA | about 12 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The company develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was founded in 2017 and is headquartered in Boulder, Colorado.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Muscular Dystrophy Small Molecule Therapies Limb Girdle Muscular Dystrophies Muscle Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Muscular Dystrophy Small Molecule Therapies Limb Girdle Muscular Dystrophies Muscle Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 20.6899 |
52 Week Low | 5.12 |
Average Volume | 734,981 |
200-Day Moving Average | 10.58 |
50-Day Moving Average | 16.79 |
20-Day Moving Average | 16.40 |
10-Day Moving Average | 15.84 |
Average True Range | 1.00 |
RSI (14) | 48.72 |
ADX | 11.76 |
+DI | 21.58 |
-DI | 19.01 |
Chandelier Exit (Long, 3 ATRs) | 16.21 |
Chandelier Exit (Short, 3 ATRs) | 17.90 |
Upper Bollinger Bands | 18.13 |
Lower Bollinger Band | 14.66 |
Percent B (%b) | 0.43 |
BandWidth | 21.15 |
MACD Line | -0.30 |
MACD Signal Line | -0.29 |
MACD Histogram | -0.0153 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 17.59 | ||||
Resistance 3 (R3) | 17.68 | 17.31 | 17.35 | ||
Resistance 2 (R2) | 17.31 | 16.95 | 17.26 | 17.27 | |
Resistance 1 (R1) | 16.74 | 16.72 | 17.02 | 16.64 | 17.19 |
Pivot Point | 16.36 | 16.36 | 16.50 | 16.31 | 16.36 |
Support 1 (S1) | 15.79 | 16.00 | 16.08 | 15.70 | 15.15 |
Support 2 (S2) | 15.42 | 15.78 | 15.37 | 15.07 | |
Support 3 (S3) | 14.85 | 15.42 | 14.99 | ||
Support 4 (S4) | 14.75 |